Robert J Bertolini's Net Worth

$11.2 Million

Estimate Recalculated Nov 11, 2024 07:48AM EST

Who is Robert J Bertolini

Robert J Bertolini has an estimated net worth of $11.2 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, GENZYME CORP, SCHERING PLOUGH CORP, and CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

SEC CIK

Robert J Bertolini's CIK is 0001270263

Past Insider Trading and Trends

2020 was Robert J Bertolini's most active year for acquiring shares with 11 total transactions. Robert J Bertolini's most active month to acquire stocks was the month of April. 2018 was Robert J Bertolini's most active year for disposing of shares, totalling 91 transactions. Robert J Bertolini's most active month to dispose stocks was the month of December. 2009 saw Robert J Bertolini paying a total of $1,485,997.67 for 379,303 shares, this is the most they've acquired in one year. In 2020 Robert J Bertolini cashed out on 21,400 shares for a total of $1,838,081.72, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BRISTOL MYERS SQUIBB CO

Investor
Updated Apr 02, 2021
Form 4
2.12%
554.41
$63.13
$35.00K
Apr 02, 2021
26.65K
Grant
Mar 31
Form 4
13.26%
3.05K
$62.21
$190.00K
Feb 03, 2021
26.09K
Grant
Feb 01
Form 4
2.53%
564.24
$62.03
$35.00K
Jan 05, 2021
22.86K
Grant
Dec 31
Form 4
2.69%
580.53
$60.29
$35.00K
Oct 02, 2020
22.13K
Grant
Sep 30
Form 4
2.86%
595.24
$58.80
$35.00K
Jul 02, 2020
21.38K
Grant
Jun 30
Form 4
3.14%
627.91
$55.74
$35.00K
Apr 02, 2020
20.64K
Grant
Mar 31
Form 4
17.77%
3.02K
$62.95
$190.00K
Feb 04, 2020
20.01K
Grant
Feb 01
Form 4
3.16%
516.05
$64.19
$33.12K
Jan 03, 2020
16.87K
Grant
Dec 31
Form 4
4.19%
653.22
$50.71
$33.12K
Oct 02, 2019
16.24K
Grant
Sep 30
Form 4
2,770.78%
11.00K
$44.72
$491.92K
Aug 01, 2019
11.40K
Purchase
Jul 31
Form 4
4.96%
730.43
$45.35
$33.13K
Jul 02, 2019
15.44K
Grant
Jun 30
Form 4
5.00%
694.30
$47.71
$33.13K
Apr 02, 2019
14.59K
Grant
Mar 31
Form 4
36.42%
3.71K
$49.89
$185.00K
Feb 05, 2019
13.89K
Grant
Feb 01
Form 4
6.83%
637.26
$51.98
$33.12K
Jan 03, 2019
9.97K
Grant
Dec 31
Form 4
6.06%
533.59
$62.08
$33.13K
Oct 02, 2018
9.33K
Grant
Sep 30
Form 4
7.10%
583.41
$55.34
$32.29K
Jul 03, 2018
8.80K
Grant
Jun 30
Form 4
6.31%
484.19
$63.25
$30.63K
Apr 03, 2018
8.15K
Grant
Mar 31
Form 4
62.38%
2.95K
$62.80
$185.00K
Feb 05, 2018
7.67K
Grant
Feb 01
Form 4
11.92%
499.75
$61.28
$30.62K
Jan 03, 2018
4.69K
Grant
Dec 31
Form 4
13.03%
480.47
$63.74
$30.63K
Oct 03, 2017
4.17K
Grant
Sep 30
Form 4
16.38%
515.23
$55.72
$28.71K
Jul 05, 2017
3.66K
Grant
Jun 30
Form 4
6.81%
199.22
$54.38
$10.83K
Apr 04, 2017
3.12K
Grant
Mar 31
Form 4
2.92K
$54.78
$160.22K
Feb 23, 2017
2.92K
Grant
Feb 21
Form 3
Feb 23, 2017
397.00
Showing 24 results

GENZYME CORP

Investor
Updated Apr 06, 2011
Form 4
-100.00%
-19.00K
$62.24
-$1.07M
Apr 06, 2011
Options
Apr 04
Form 4
400.00%
9.50K
$51.52
$367.08K
Jun 18, 2010
11.88K
Options
Jun 16
Form 4
9.50K
$49.42
$352.12K
Dec 10, 2009
9.50K
Grant
Dec 08
Form 3
Dec 10, 2009
Showing 4 results

SCHERING PLOUGH CORP

Executive Vice President
Updated Nov 04, 2009
Form 4
-100.00%
-2.14M
Nov 04, 2009
Disposition
Nov 03
Form 4
264.60K
May 05, 2009
264.60K
Grant
May 01
Form 4
-15.05%
-18.54K
$23.70
-$439.40K
Apr 03, 2009
110.70K
Options
Apr 01
Form 4
65.20K
$17.39
$1.13M
Mar 03, 2009
65.20K
Grant
Feb 27
Form 4
260.00K
May 05, 2008
260.00K
Grant
May 01
Form 4
-14.48%
-20.86K
$18.64
-$388.79K
Apr 29, 2008
129.15K
Options
Apr 25
Form 4
345.00K
May 03, 2007
345.00K
Grant
May 01
Form 4
-12.65%
-20.86K
$21.93
-$457.42K
Dec 04, 2006
149.92K
Options
Dec 01
Form 4
-15.45%
-30.13K
$21.98
-$662.21K
Nov 20, 2006
170.78K
Options
Nov 17
Form 4
180.65%
280.00K
May 23, 2006
435.00K
Grant
May 19
Form 4
5.85K
$19.60
$114.72K
Nov 18, 2005
5.85K
Acq/Dis
Nov 17
Form 4
268.18%
295.00K
Apr 27, 2005
405.00K
Grant
Apr 25
Form 4
979.92%
636.95K
Feb 25, 2004
701.95K
Grant
Feb 23
Form 4
415.00K
Nov 19, 2003
415.00K
Purchase
Nov 17
Form 3
Nov 19, 2003
Showing 15 results

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Investor
Updated May 15, 2024
Form 4
7.11%
2.26K
$228.41
$517.12K
May 15, 2024
34.11K
Grant
May 13
Form 4
9.12%
2.80K
$192.36
$321.05K
May 17, 2023
33.52K
Grant
May 15
Form 4
8.62%
2.56K
$222.31
$351.69K
May 13, 2022
32.30K
Grant
May 11
Form 4
6.02%
1.75K
May 10, 2021
30.89K
Grant
May 07
Form 4
-10.81%
-3.53K
$113.44
-$431.68K
May 21, 2020
29.13K
Sale
May 20
Form 4
13.63%
3.80K
May 12, 2020
31.67K
Grant
May 11
Form 4
-20.46%
-7.17K
$112.79
-$826.25K
Feb 14, 2020
27.88K
Sale
Feb 13
Form 4
10.02%
2.54K
May 23, 2019
27.88K
Grant
May 22
Form 4
-4.16%
-1.10K
$134.71
-$148.18K
Dec 06, 2018
25.34K
Sale
Dec 04
Form 4
-11.51%
-3.44K
$83.85
-$306.11K
Dec 06, 2018
26.44K
Sale
Dec 04
Form 4
12.18%
2.75K
May 15, 2018
25.34K
Grant
May 14
Form 4
-13.78%
-3.61K
$110.22
-$397.78K
Jan 03, 2018
22.59K
Sale
ScheduledJan 02
Form 4
-13.62%
-4.13K
$74.93
-$141.03K
Jan 03, 2018
26.20K
Sale
ScheduledJan 02
Form 4
12.09%
2.44K
May 15, 2017
22.59K
Grant
May 12
Form 4
-25.05%
-6.74K
$88.00
-$592.70K
Mar 02, 2017
20.15K
Sale
Mar 01
Form 4
-16.35%
-5.25K
$62.67
-$6.65K
Mar 02, 2017
26.89K
Sale
Mar 01
Form 4
12.63%
2.26K
May 16, 2016
20.15K
Grant
May 12
Form 4
32.10%
5.11K
May 07, 2015
21.03K
Grant
May 06
Form 4
47.35%
6.25K
May 09, 2014
19.45K
Grant
May 07
Form 4
72.99%
7.27K
May 10, 2013
17.23K
Grant
May 08
Form 4
144.93%
8.58K
May 11, 2012
14.50K
Grant
May 09
Form 4
275.27%
10.02K
May 13, 2011
13.66K
Grant
May 11
Form 4
15.63K
$37.81
$453.34K
Feb 03, 2011
15.63K
Grant
Feb 01
Form 3
Jan 28, 2011
Showing 24 results